NCT00294294View on ClinicalTrials.gov

Study Evaluating Treatment of Fever in Children Who Have Been Vaccinated With Prevenar and Infanrix Hexa

PHASE4CompletedINTERVENTIONAL

Enrollment

300

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

December 31, 2006

Study Completion Date

December 31, 2006

Conditions

Vaccines, PneumococcalInfantFever, Chemically InducedDrug Therapy, Combination

Interventions

BIOLOGICAL

Prevenar

BIOLOGICAL

Infanrix hexa

All Listed Sponsors

lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00294294 - Study Evaluating Treatment of Fever in Children Who Have Been Vaccinated With Prevenar and Infanrix Hexa | Biotech Hunter | Biotech Hunter